Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations - Top-Institutions - MDSpire

Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations

  • By

  • Ziyun Wang

  • Yijin Wang

  • Wangning Shangguan

  • Tao Li

  • June 9, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology

  • #2

    Duke University Health System
    Duke University Health System

    Durham, North Carolina

    Key Differentiators

    • Cardiology

  • #3

    Medical University of South Carolina
    Medical University of South Carolina

    Charleston, South Carolina

    Key Differentiators

    • Cardiology

  • #4

    Aarhus University
    Aarhus University

    Aarhus, Denmark

    Key Differentiators

    • Cardiology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Cardiology

Original Source(s)

Cardiovascular protection by SGLT2 inhibitors: an integrative review of mechanistic networks, clinical evidence, and safety considerations

  • by Ziyun Wang, Yijin Wang, Wangning Shangguan, Tao Li

  • June 9, 2026

Related Content

Association of estimated glomerular filtration rate and in-hospital mortality in patients hospitalized for heart failure: a retrospective cohort study

Abnormal active myocardial relaxation by dipyridamole stress test in suspected early-stage heart failure with preserved ejection fraction: a retrospective exploratory analysis

Concomitant transcatheter edge-to-edge treatment for mitral regurgitation and the K-Clip system for tricuspid regurgitation: one case report